Drugs that contain Calcitriol
1. Calcijex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6051567 | ABBVIE | Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol |
Aug, 2019
(4 years ago) | |
| US6274169 | ABBVIE | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
Aug, 2019
(4 years ago) | |
| US6265392 | ABBVIE | Low oxygen content compositions of 1α, 25-dihydroxycholeclciferol |
Aug, 2019
(4 years ago) | |
|
US6265392 (Pediatric) | ABBVIE | Low oxygen content compositions of 1α, 25-dihydroxycholeclciferol |
Feb, 2020
(4 years ago) | |
|
US6274169 (Pediatric) | ABBVIE | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
Feb, 2020
(4 years ago) | |
|
US6051567 (Pediatric) | ABBVIE | Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol |
Feb, 2020
(4 years ago) | |
Market Authorisation Date: 25 September, 1986
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of CALCIJEX before it's drug patent expiration?
More Information on Dosage
CALCIJEX family patents
